Antibacterial, antibiofilm, and antiviral farnesol-containing nanoparticles prevent Staphylococcus aureus from drug resistance development

Carregant...
Miniatura
El pots comprar en digital a:
El pots comprar en paper a:

Projectes de recerca

Unitats organitzatives

Número de la revista

Títol de la revista

ISSN de la revista

Títol del volum

Cita com:

Col·laborador

Editor

Tribunal avaluador

Realitzat a/amb

Tipus de document

Article

Data publicació

Editor

Condicions d'accés

Accés obert

Llicència

Creative Commons
Aquesta obra està protegida pels drets de propietat intel·lectual i industrial corresponents. Llevat que s'hi indiqui el contrari, els seus continguts estan subjectes a la llicència de Creative Commons: Reconeixement-NoComercial-SenseObraDerivada 4.0 Internacional

Assignatures relacionades

Assignatures relacionades

Publicacions relacionades

Datasets relacionats

Datasets relacionats

Projecte CCD

Abstract

Multidrug antimicrobial resistance is a constantly growing health care issue associated with increased mortality and morbidity, and huge financial burden. Bacteria frequently form biofilm communities responsible for numerous persistent infections resistant to conventional antibiotics. Herein, novel nanoparticles (NPs) loaded with the natural bactericide farnesol (FSL NPs) are generated using high-intensity ultrasound. The nanoformulation of farnesol improved its antibacterial properties and demonstrated complete eradication of Staphylococcus aureus within less than 3 h, without inducing resistance development, and was able to 100% inhibit the establishment of a drug-resistant S. aureus biofilm. These antibiotic-free nano-antimicrobials also reduced the mature biofilm at a very low concentration of the active agent. In addition to the outstanding antibacterial properties, the engineered nano-entities demonstrated strong antiviral properties and inhibited the spike proteins of SARS-CoV-2 by up to 83%. The novel FSL NPs did not cause skin tissue irritation and did not induce the secretion of anti-inflammatory cytokines in a 3D skin tissue model. These results support the potential of these bio-based nano-actives to replace the existing antibiotics and they may be used for the development of topical pharmaceutic products for controlling microbial skin infections, without inducing resistance development.

Descripció

Persones/entitats

Document relacionat

Versió de

Citació

Asenova, A. [et al.]. Antibacterial, antibiofilm, and antiviral farnesol-containing nanoparticles prevent Staphylococcus aureus from drug resistance development. "International journal of molecular sciences", 7 Juliol 2022, vol. 23, núm. 7527, p. 1-16.

Ajut

Forma part

Dipòsit legal

ISBN

ISSN

1422-0067

Altres identificadors

Referències